DarioHealth Statistics
Total Valuation
DarioHealth has a market cap or net worth of $59.21 million. The enterprise value is $64.94 million.
Important Dates
The last earnings date was Thursday, March 19, 2026, before market open.
| Earnings Date | Mar 19, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
DarioHealth has 7.30 million shares outstanding. The number of shares has increased by 62.44% in one year.
| Current Share Class | 7.30M |
| Shares Outstanding | 7.30M |
| Shares Change (YoY) | +62.44% |
| Shares Change (QoQ) | +152.08% |
| Owned by Insiders (%) | 19.94% |
| Owned by Institutions (%) | 4.96% |
| Float | 5.27M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.65 |
| Forward PS | 2.22 |
| PB Ratio | 0.82 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.90 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.76, with a Debt / Equity ratio of 0.47.
| Current Ratio | 3.76 |
| Quick Ratio | 3.08 |
| Debt / Equity | 0.47 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -12.14 |
Financial Efficiency
Return on equity (ROE) is -59.62% and return on invested capital (ROIC) is -22.70%.
| Return on Equity (ROE) | -59.62% |
| Return on Assets (ROA) | -20.01% |
| Return on Invested Capital (ROIC) | -22.70% |
| Return on Capital Employed (ROCE) | -36.38% |
| Weighted Average Cost of Capital (WACC) | 9.54% |
| Revenue Per Employee | $135,509 |
| Profits Per Employee | -$244,300 |
| Employee Count | 165 |
| Asset Turnover | 0.20 |
| Inventory Turnover | 1.77 |
Taxes
In the past 12 months, DarioHealth has paid $105,000 in taxes.
| Income Tax | 105,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -38.12% in the last 52 weeks. The beta is 1.16, so DarioHealth's price volatility has been higher than the market average.
| Beta (5Y) | 1.16 |
| 52-Week Price Change | -38.12% |
| 50-Day Moving Average | 10.26 |
| 200-Day Moving Average | 11.77 |
| Relative Strength Index (RSI) | 39.54 |
| Average Volume (20 Days) | 12,940 |
Short Selling Information
The latest short interest is 44,799, so 0.61% of the outstanding shares have been sold short.
| Short Interest | 44,799 |
| Short Previous Month | 50,473 |
| Short % of Shares Out | 0.61% |
| Short % of Float | 0.85% |
| Short Ratio (days to cover) | 5.16 |
Income Statement
In the last 12 months, DarioHealth had revenue of $22.36 million and -$40.31 million in losses. Loss per share was -$10.12.
| Revenue | 22.36M |
| Gross Profit | 14.34M |
| Operating Income | -36.66M |
| Pretax Income | -41.61M |
| Net Income | -40.31M |
| EBITDA | -33.52M |
| EBIT | -36.66M |
| Loss Per Share | -$10.12 |
Full Income StatementBalance Sheet
The company has $26.02 million in cash and $31.75 million in debt, with a net cash position of -$5.73 million or -$0.79 per share.
| Cash & Cash Equivalents | 26.02M |
| Total Debt | 31.75M |
| Net Cash | -5.73M |
| Net Cash Per Share | -$0.79 |
| Equity (Book Value) | 67.92M |
| Book Value Per Share | 9.84 |
| Working Capital | 25.74M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$25.94 million and capital expenditures -$142,000, giving a free cash flow of -$26.08 million.
| Operating Cash Flow | -25.94M |
| Capital Expenditures | -142,000 |
| Depreciation & Amortization | 3.14M |
| Net Borrowing | 185,000 |
| Free Cash Flow | -26.08M |
| FCF Per Share | -$3.57 |
Full Cash Flow StatementMargins
Gross margin is 64.11%, with operating and profit margins of -163.94% and -186.56%.
| Gross Margin | 64.11% |
| Operating Margin | -163.94% |
| Pretax Margin | -186.10% |
| Profit Margin | -186.56% |
| EBITDA Margin | -149.90% |
| EBIT Margin | -163.94% |
| FCF Margin | n/a |
Dividends & Yields
DarioHealth does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -62.44% |
| Shareholder Yield | -62.44% |
| Earnings Yield | -68.08% |
| FCF Yield | -44.05% |
Analyst Forecast
The average price target for DarioHealth is $35.00, which is 331.57% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $35.00 |
| Price Target Difference | 331.57% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 17.63% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 28, 2025. It was a reverse split with a ratio of 1:20.
| Last Split Date | Aug 28, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
DarioHealth has an Altman Z-Score of -5.75 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.75 |
| Piotroski F-Score | 2 |
